PATENT CLAIM ANALYSIS

Application Number: 16016458
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "267000"]

Abstract:
Disclosed is a method of promoting wound healing with reduced scarring after glaucoma filtration surgery in a mammalian subject in need thereof, which involve the use of a HDAC inhibitor (HDACi), such as, but not limited to, suberoylanilide hydroxamic acid (SAHA).

Claim (Index 1):
A method of promoting wound healing with reduced scarring after glaucoma filtration surgery in a mammalian subject in need thereof, comprising administering an effective amount of a HDAC inhibitor (HDACi) to said subject.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 94.0
- Lexical Diversity: 1.21951
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['10398677', '12321812', '15759203', '16000678', '15120065']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7393754677427141
- 35 USC 102 Novelty (BERT): 0.497860847460897
- Combined Prediction Score: 0.7152240057145324
- Mean Citation Score: 207.414164
- Max Citation Score: 222.70969
- Similarity Product: 154.1178204934728

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test